At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to advancing scientific understanding through the provision of high-quality research chemicals. Obeticholic Acid (CAS: 459789-99-2) stands out as a prime example of a compound with profound scientific implications, particularly in the realm of liver disease. As a potent and selective farnesoid X receptor (FXR) agonist, its mechanism of action is central to its therapeutic potential.

The core of Obeticholic Acid's activity lies in its ability to activate FXR, a nuclear receptor that governs a wide array of physiological processes. These include the regulation of bile acid synthesis and transport, lipid metabolism, and inflammatory responses. For individuals with liver conditions such as NASH, where these pathways are disrupted, Obeticholic Acid offers a targeted intervention. The scientific literature extensively details the obeticholic acid efficacy for NASH patients, demonstrating its capacity to ameliorate key disease markers.

Understanding the science also involves a thorough assessment of the obeticholic acid safety profile. While its therapeutic benefits are significant, potential side effects, including pruritus, need careful consideration. Research into the obeticholic acid adverse effects pruritus aims to elucidate the mechanisms and develop strategies for effective management, ensuring patient comfort and treatment adherence.

For researchers exploring innovative treatments, the ability to readily access reliable sources to buy Obeticholic Acid online is crucial. NINGBO INNO PHARMCHEM CO.,LTD. provides a dependable supply of this compound, supporting vital scientific investigations. Familiarity with the detailed obeticholic acid chemical properties further enhances its utility in complex research protocols and drug development pipelines.

The scientific community's interest in Obeticholic Acid continues to grow, driven by its promising applications in addressing unmet medical needs. By supplying high-purity Obeticholic Acid, NINGBO INNO PHARMCHEM CO.,LTD. plays a supportive role in this ongoing scientific endeavor, enabling researchers to unlock the full potential of this remarkable FXR agonist.